Literature DB >> 1380001

Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity.

R Flaumenhaft1, M Abe, P Mignatti, D B Rifkin.   

Abstract

Exposure of bovine aortic or capillary endothelial cells to basic FGF (bFGF) for 1 h resulted in an approximately sixfold increase in plasminogen activator (PA) activity by 18 h that returned nearly to basal levels by 36 h. We hypothesized that the decrease in PA activity following bFGF stimulation was mediated by transforming growth factor beta (TGF-beta) formed from its inactive precursor. Conditioned medium collected from endothelial cells 36 h after a 1-h exposure to bFGF, but not control medium, inhibited basal levels of PA activity when transferred to confluent monolayers of bovine aortic endothelial cells. Antibody to TGF-beta neutralized the inhibitory activity of this conditioned medium, indicating that the medium contained active TGF-beta. Northern blot analysis and quantitation of acid activatable latent TGF-beta in conditioned medium demonstrated that bFGF exposure did not increase the amount of transcription or secretion of latent TGF-beta by the endothelial cells. Both aprotinin, an inhibitor of plasmin, and anti-urokinase type PA IgG blocked the generation of active TGF-beta in cultures exposed to bFGF. These results demonstrated that plasmin generated by uPA activity is required for the activation of latent TGF-beta in endothelial cell cultures treated with bFGF. Activation of TGF-beta by endothelial cells exposed to bFGF appears to limit both the degree and duration of PA stimulation. Thus, in bFGF-stimulated endothelial cell cultures, PA levels are controlled by a negative feedback loop: PA, whose expression is stimulated by bFGF, contributes to the formation of TGF-beta, which in turn opposes the effects of bFGF by limiting PA synthesis and activity. These studies suggest a role for TGF-beta in reversing the invasive stage of angiogenesis and contributing to the formation of quiescent capillaries.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380001      PMCID: PMC2289566          DOI: 10.1083/jcb.118.4.901

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  54 in total

1.  Basic fibroblast growth factor induces angiogenesis in vitro.

Authors:  R Montesano; J D Vassalli; A Baird; R Guillemin; L Orci
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration.

Authors:  D Moscatelli; M Presta; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Activation of the bone-derived latent TGF beta complex by isolated osteoclasts.

Authors:  R O Oreffo; G R Mundy; S M Seyedin; L F Bonewald
Journal:  Biochem Biophys Res Commun       Date:  1989-02-15       Impact factor: 3.575

4.  Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture.

Authors:  D Danielpour; L L Dart; K C Flanders; A B Roberts; M B Sporn
Journal:  J Cell Physiol       Date:  1989-01       Impact factor: 6.384

5.  Deactivation of macrophages by transforming growth factor-beta.

Authors:  S Tsunawaki; M Sporn; A Ding; C Nathan
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

6.  The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells.

Authors:  M C Kuppner; M F Hamou; S Bodmer; A Fontana; N de Tribolet
Journal:  Int J Cancer       Date:  1988-10-15       Impact factor: 7.396

7.  Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization.

Authors:  K Miyazono; U Hellman; C Wernstedt; C H Heldin
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

8.  Endothelial cell behavior after denudation injury is modulated by transforming growth factor-beta1 and fibronectin.

Authors:  J A Madri; M A Reidy; O Kocher; L Bell
Journal:  Lab Invest       Date:  1989-06       Impact factor: 5.662

9.  The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells.

Authors:  O Saksela; D Moscatelli; D B Rifkin
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

10.  Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix.

Authors:  J A Madri; B M Pratt; A M Tucker
Journal:  J Cell Biol       Date:  1988-04       Impact factor: 10.539

View more
  36 in total

1.  Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1.

Authors:  M V Cronauer; S Stadlmann; H Klocker; B Abendstein; I E Eder; H Rogatsch; A G Zeimet; C Marth; F A Offner
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

Authors:  E P Böttinger; V M Factor; M L Tsang; J A Weatherbee; J B Kopp; S W Qian; L M Wakefield; A B Roberts; S S Thorgeirsson; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 3.  Angiogenic growth factors in neural embryogenesis and neoplasia.

Authors:  D Zagzag
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

4.  Active transforming growth factor-beta in wound repair: determination using a new assay.

Authors:  L Yang; C X Qiu; A Ludlow; M W Ferguson; G Brunner
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

5.  Molecular atherectomy for restenosis.

Authors:  W Casscells; D A Lappi; A Baird
Journal:  Trends Cardiovasc Med       Date:  1993 Nov-Dec       Impact factor: 6.677

Review 6.  Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix.

Authors:  John S Munger; Dean Sheppard
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-11-01       Impact factor: 10.005

7.  αvβ1 integrin as a novel therapeutic target for tissue fibrosis.

Authors:  Kyung-Hee Song; Seong-Jun Cho; Jie-Young Song
Journal:  Ann Transl Med       Date:  2016-10

8.  Latency-associated peptide of transforming growth factor-β1 is not subject to physiological mannose phosphorylation.

Authors:  Jarrod Barnes; Debra Warejcka; Jennifer Simpliciano; Sally Twining; Richard Steet
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

9.  Membrane-Type 1 Matrix Metalloproteinase Downregulates Fibroblast Growth Factor-2 Binding to the Cell Surface and Intracellular Signaling.

Authors:  Evelyne Tassone; Cristina Valacca; Paolo Mignatti
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

10.  Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

Authors:  S Kagami; W A Border; D E Miller; N A Noble
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.